g10 fx
Barclays upgrades Alvotech stock rating on FDA approval outlook By Investing.com - Investing.com Nigeria
From the original
Barclays upgrades Alvotech stock rating on FDA approval outlook By Investing.com Investing.com Nigeria
Related speeches
4 itemsBarclays reiterates Broadcom stock rating on AI revenue outlook By Investing.com - Investing.com South Africa
Deutsche Bank upgrades AstraZeneca stock rating to hold on trial results - Investing.com Nigeria
Barclays upgrades Soitec to Overweight, lifts target to €200 on photonics growth - Investing.com Nigeria
Barclays Picks Two Large-Cap Pharma Winners for 2027 as Sector Outlook Turns Cautious - Investing.com Nigeria
More like this
5 itemsBarclays reinstates Smiths Group coverage, sees growth headwinds By Investing.com - Investing.com Nigeria
Barclays starts bullish coverage on Hill & Smith on U.S. infrastructure demand - Investing.com Nigeria
Barclays upgrades Soitec to Overweight, lifts target to €200 on photonics growth - Investing.com Nigeria
Barclays expects BoE rate hikes in November and February on inflation risks - Investing.com Nigeria